|本期目录/Table of Contents|

[1]金 翎,崔 晓,蔡 军.高血压超重人群肠道菌群的研究[J].传染病信息,2018,04:320-325.
 JIN Ling,CUI Xiao,CAI Jun*.Study of gut microbiota in over-weighted and obese hypertensive patients[J].Infectious Disease Information,2018,04:320-325.
点击复制

高血压超重人群肠道菌群的研究(PDF)

《传染病信息》[ISSN:1007-8134/CN:11-3886/R]

期数:
2018年04期
页码:
320-325
栏目:
论 著
出版日期:
2018-08-30

文章信息/Info

Title:
Study of gut microbiota in over-weighted and obese hypertensive patients
作者:
金 翎崔 晓蔡 军
 100037 北京,中国医学科学院阜外医院高血压 中心(金翎、崔晓、蔡军)
Author(s):
JIN Ling CUI Xiao CAI Jun*
Hypertension Center, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China
关键词:
肠道菌群高血压超重/ 肥胖
Keywords:
gut microbiota hypertension overweight/obesity
分类号:
R37;R544.1
DOI:
10.3969/j.issn.1007-8134.2018.04.005
文献标识码:
A
摘要:
目的 探讨高血压超重/ 肥胖患者肠道菌群的变化及功能的改变。方法 收集年龄段在45 ~ 60 岁的健 康人68 例(血压正常组),高血压患者73 例(高血压组)。再根据身高体质量指数值,进一步将高血压组分为高血 压体质量正常组和高血压超重/ 肥胖组,采用宏基因组测序技术检测各组样本肠道菌群的种类及功能。结果 高血压 组的阴沟肠杆菌属细菌的丰度相对于正常血压组显著降低(P=0.018),而副杆菌属细菌的丰度在高血压组中略有增多 (P=0.042)。在高血压人群中观察到克雷伯菌属细菌、固氮螺菌属细菌、阿克曼属细菌和小杆菌属细菌在高血压超重/ 肥胖组的丰度相对于高血压体质量正常组显著升高,P 值分别为0.015、0.046、0.022 和0.004;而高血压超重/ 肥胖组中 副杆菌属细菌的丰度比高血压体质量正常组显著降低(P=0.046)。此外,与高血压体质量正常组相比,与序列特异性的 DNA 结合功能、转录调节功能相关的菌群丰度在高血压超重/ 肥胖组中显著增加(q < 0.05)。结论 高血压超重/ 肥 胖患者肠道菌群的种类及功能均有改变,提示我们可以通过有效的干预措施改变微生物菌群组成,从而影响其体质量和 血压。    
Abstract:
Objective To investigate the changes of composition and functional patterns of gut microbiota in over-weighted and obese hypertensive patients. Methods Seventy-three hypertensive patients and 68 healthy controls aged 45-60 years were enrolled in this study. They were divided into healthy group and hypertension group according to blood pressure value. Furthermore, subgroups of normal body weight and overweight/obesity were further sorted in hypertension group based on the values of BMI. Metagenomic sequencing analysis was applied to detect the composition and function of gut microbiota in collected samples of each group. Results Enterobacter cloacae abundance was significantly decreased in the hypertension group compared with normal BP group (P=0.018), however, parabacteroides abundance was slightly higher in the hypertension group (P=0.042). Among hypertensive patients, the abundance of Klebsiella, Azospirillum, Akkermansia and Dialister in the overweight/obesity subgroup was significantly higher than that in normal body weight subgroup (P= 0.015, 0.046, 0.022, 0.004 respectively), while parabacteroides abundance was significantly lower in the overweight/obesity subgroup (P=0.046). Compared with normal body weight subgroup, the abundance of microbiota associated with the functions of sequence-specific DNA binding and transcriptional regulation was significantly increased in the overweight/obesity subgroup of hypertensive patients (q < 0.05). Conclusions Changes of composition and functional patterns of gut microbiota in over-weighted/obese hypertensive patients indicate a possibility of early effective intervention on body weight and blood pressure through altering the composition of gun microbiota.

参考文献/References


[1] Yang T, Santisteban MM, Rodriguez V, et al. Gut dysbiosis is linked to hypertension[J]. Hypertension, 2015, 65(6):1331-1340.
[2] Mell B, Jala VR, Mathew AV, et al. Evidence for a link between gut microbiota and hypertension in the Dahl rat[J]. Physiol Genomics, 2015, 47(6):187-197.
[3] Li J, Zhao F, Wang Y, et al. Gut microbiota dysbiosis contributes to the development of hypertension[J]. Microbiome, 2017, 5(1):14.
[4] Jokinen E. Obesity and cardiovascular disease[J]. Minerva pediatr, 2015, 67(1):25-32.
[5] Ebbert JO, Elrashidi MY, Jensen MD. Managing overweight and obesity in adults to reduce cardiovascular disease risk[J]. Curr Atheroscler Rep, 2014, 16(10):445.
[6] NHLBI Obesity Education Initiative Expert Panel. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults[J]. Obes Res, 1998, 6(Suppl 2):S51-S209.
[7] Fei N, Zhao L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice[J]. ISME J, 2013, 7(4):880-884.
[8] Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage[J]. Proc Natl Acad Sci U S A, 2004, 101(44):15718-15723.
[9] Hubert H, Feinleib M, McNamara P, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study[J]. Circulation, 1983, 67(5):968-977.
[10] Noor S, Ridgway K, Scovell L, et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota [J]. BMC gastroenterol, 2010, 10:134.
[11] Wu TR, Lin CS, Chang CJ, et al. Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis[EB/OL]. [2018- 06-18]. https://www.researchgate.net/publication/326402259_Gut_ commensal_Parabacteroides_goldsteinii_plays_a_predominant_ role_in_the_anti-obesity_effects_of_polysaccharides_isolated_ from_Hirsutella_sinensis.
[12] 黄坤,吴丽丽,杨云生. 肠道微生态与人类疾病关系的研究 进展[J]. 传染病信息,2017,30(3):133-137.
[13] Khalesi S, Sun J, Buys N, et al. Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials[J]. Hypertension, 2014, 64(4):897-903.
[14] Gómez-Guzmán M, Toral M, Romero M, et al. Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats [J]. Mol Nutr Food Res, 2015, 59(11):2326- 2336.
[15] Membrez M, Blancher F, Jaquet M, et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice [J]. FASEB J, 2008, 22(7):2416-2426.
[16] Wang A, Wu J, Zhou Y, et al. Measures of adiposity and risk of stroke in China: a result from the Kailuan study[J]. PLoS One, 2013, 8(4):e61665.

备注/Memo

备注/Memo:
[ 基金项目] 国家自然科学基金(81470541,81630014, 81700374) [ 作者单位] 100037 北京,中国医学科学院阜外医院高血压 中心(金翎、崔晓、蔡军) [ 通信作者] 蔡军,E-mail: caijun@fuwaihospital.org
更新日期/Last Update: 2018-09-08